Giant cell tumor of bone: Effect of longer dosing intervals of denosumab on tumor control and bone related complications.

11525Background: Giant cell tumor of bone (GCTB) is a benign but locally aggressive bone neoplasm characterized by osteoclast activation causing destructive osteolysis. Denosumab, a human monoclona...